Cavernous angioma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category: | [[Category:Up to Date]] | ||
Latest revision as of 12:37, 12 May 2022
|
Cavernous angioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cavernous angioma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Cavernous angioma other diagnostic studies |
|
Risk calculators and risk factors for Cavernous angioma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Diagnostic biomarkers can be utilized too in conjunction with imaging tools to identify cavernous angioma.
Other Diagnostic Studies
Diagnostic biomarkers can be utilized too in conjunction with imaging tools to identify cavernous angioma.[1]
References
- ↑ Sone JY, Li Y, Hobson N, Romanos SG, Srinath A, Lyne SB; et al. (2021). "Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage". J Cereb Blood Flow Metab. 41 (11): 2944–2956. doi:10.1177/0271678X211020587. PMC 8756480 Check
|pmc=value (help). PMID 34039038 Check|pmid=value (help).